These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1996795)

  • 1. The adsorption of salicylates by a milk chocolate-charcoal mixture.
    Eisen TF; Grbcich PA; Lacouture PG; Shannon MW; Woolf A
    Ann Emerg Med; 1991 Feb; 20(2):143-6. PubMed ID: 1996795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large surface area activated charcoal and the inhibition of aspirin absorption.
    Dillon EC; Wilton JH; Barlow JC; Watson WA
    Ann Emerg Med; 1989 May; 18(5):547-52. PubMed ID: 2719366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the palatability of activated charcoal in pediatric patients.
    Cheng A; Ratnapalan S
    Pediatr Emerg Care; 2007 Jun; 23(6):384-6. PubMed ID: 17572522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of commercially available aqueous activated charcoal products.
    Krenzelok EP; Heller MB
    Ann Emerg Med; 1987 Dec; 16(12):1340-3. PubMed ID: 3688595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acetaminophen ingestion with a superactivated charcoal-cola mixture.
    Rangan C; Nordt SP; Hamilton R; Ingels M; Clark RF
    Ann Emerg Med; 2001 Jan; 37(1):55-8. PubMed ID: 11145772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model.
    Johnson D; Eppler J; Giesbrecht E; Verjee Z; Rais A; Wiggins T; Fraga C; Ito S
    Ann Emerg Med; 1995 Nov; 26(5):569-74. PubMed ID: 7486364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
    Olsen KM; Ma FH; Ackerman BH; Stull RE
    Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative efficacy and palatability of three activated charcoal mixtures.
    Navarro RP; Navarro KR; Krenzelok EP
    Vet Hum Toxicol; 1980 Feb; 22(1):6-9. PubMed ID: 7361450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal.
    Sketris IS; Mowry JB; Czajka PA; Anderson WH; Stafford DT
    J Clin Pharmacol; 1982 Jan; 22(1):59-64. PubMed ID: 7061727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro adsorption of sodium pentobarbital by SuperChar, USP and Darco G-60 activated charcoals.
    Curd-Sneed CD; Parks KS; Bordelon JG; Stewart JJ
    J Toxicol Clin Toxicol; 1987; 25(1-2):1-11. PubMed ID: 3586080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption.
    Keller RE; Schwab RA; Krenzelok EP
    Ann Emerg Med; 1990 Jun; 19(6):654-6. PubMed ID: 2188536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo comparison of the adsorption capacity of "superactive charcoal" and fructose with activated charcoal and fructose.
    Chung DC; Murphy JE; Taylor TW
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):219-24. PubMed ID: 7109011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination.
    Ho JL; Tierney MG; Dickinson GE
    J Clin Pharmacol; 1989 Apr; 29(4):366-9. PubMed ID: 2723125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.